Eylea 40mg/ml Injection

Introduction to Eylea 40mg Injection
Eylea 40mg/ml Injection contains the active constituent Aflibercept. It is used to treat eye conditions in which impaired vision occurs due to the formation of an abnormal blood vessel inside the eye. These include wet age-related macular degeneration and diabetic macular edema. In studies, this medication effectively reduces the risk of vision loss and improves visual acuity in people with these conditions. Most patients generally well-tolerated it, and the injection procedure is relatively quick and minimally invasive.

You should avoid this medication, Eylea Injection, if you have severe hypersensitivity reactions to other anti-VEGF medications. Tell your physician if a person has glaucoma, a history of seeing floaters or flashes, and other illnesses before taking Eylea eye injection. It will not be given if you have an infection or inflammation around the eye. Tell your doctor if surgery was performed recently or planned on your eye before taking this medication.


Uses of Eylea 40mg Injection
Eylea injection uses include:

Neovascular (wet) age-related macular degeneration (wet AMD)
Diabetic macular edema (DME)
Myopic choroidal neovascularization (myopic CNV)
Macular edema secondary to retinal vein occlusion